These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 9474050)

  • 1. Making TDM work to optimize cancer chemotherapy: a multidisciplinary team approach.
    Hon YY; Evans WE
    Clin Chem; 1998 Feb; 44(2):388-400. PubMed ID: 9474050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic drug monitoring in cancer management.
    Galpin AJ; Evans WE
    Clin Chem; 1993 Nov; 39(11 Pt 2):2419-30. PubMed ID: 8222253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic drug monitoring of cancer chemotherapy.
    Alnaim L
    J Oncol Pharm Pract; 2007 Dec; 13(4):207-21. PubMed ID: 18045780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target concentration intervention in oncology: where are we at?
    Saleem M; Dimeski G; Kirkpatrick CM; Taylor PJ; Martin JH
    Ther Drug Monit; 2012 Jun; 34(3):257-65. PubMed ID: 22585183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of therapeutic drug monitoring of anticancer drugs part 1--cytotoxics.
    Paci A; Veal G; Bardin C; Levêque D; Widmer N; Beijnen J; Astier A; Chatelut E
    Eur J Cancer; 2014 Aug; 50(12):2010-9. PubMed ID: 24889915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of pharmacokinetic modelling to the routine therapeutic drug monitoring of anticancer drugs.
    Rousseau A; Marquet P
    Fundam Clin Pharmacol; 2002 Aug; 16(4):253-62. PubMed ID: 12570013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic drug monitoring of antimetabolic cytotoxic drugs.
    Lennard L
    Br J Clin Pharmacol; 1999 Feb; 47(2):131-43. PubMed ID: 10190647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic drug monitoring of cytotoxic drugs.
    Lennard L
    Br J Clin Pharmacol; 2001; 52 Suppl 1(Suppl 1):75S-87S. PubMed ID: 11564055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic drug monitoring in cancer chemotherapy.
    Bach DM; Straseski JA; Clarke W
    Bioanalysis; 2010 May; 2(5):863-79. PubMed ID: 21083218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic-pharmacokinetic relationships and therapeutic drug monitoring.
    Kobayashi K; Jodrell DI; Ratain MJ
    Cancer Surv; 1993; 17():51-78. PubMed ID: 8137353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic drug monitoring in cancer--are we missing a trick?
    Bardin C; Veal G; Paci A; Chatelut E; Astier A; Levêque D; Widmer N; Beijnen J
    Eur J Cancer; 2014 Aug; 50(12):2005-9. PubMed ID: 24878063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Personalized medicine for oral molecular-targeted anticancer drugs].
    Miura M
    Nihon Yakurigaku Zasshi; 2019; 153(2):73-78. PubMed ID: 30745517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individualised cancer chemotherapy: strategies and performance of prospective studies on therapeutic drug monitoring with dose adaptation: a review.
    de Jonge ME; Huitema AD; Schellens JH; Rodenhuis S; Beijnen JH
    Clin Pharmacokinet; 2005; 44(2):147-73. PubMed ID: 15656695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptive control methods for the dose individualisation of anticancer agents.
    Rousseau A; Marquet P; Debord J; Sabot C; Lachâtre G
    Clin Pharmacokinet; 2000 Apr; 38(4):315-53. PubMed ID: 10803455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics and therapeutic drug monitoring of anticancer agents].
    Marquet P; Rousseau A
    Bull Cancer; 2008 Oct; 95(10):903-9. PubMed ID: 19004719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic optimisation of cancer chemotherapy. Effect on outcomes.
    Masson E; Zamboni WC
    Clin Pharmacokinet; 1997 Apr; 32(4):324-43. PubMed ID: 9113440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of therapeutic drug monitoring in the management of safety of anticancer agents: a focus on 3 cytotoxics.
    Levêque D; Becker G
    Expert Opin Drug Saf; 2019 Nov; 18(11):1009-1015. PubMed ID: 31478396
    [No Abstract]   [Full Text] [Related]  

  • 18. Review of therapeutic drug monitoring of anticancer drugs part two--targeted therapies.
    Widmer N; Bardin C; Chatelut E; Paci A; Beijnen J; Levêque D; Veal G; Astier A
    Eur J Cancer; 2014 Aug; 50(12):2020-36. PubMed ID: 24928190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status and future outlooks on therapeutic drug monitoring of fluorouracil.
    Schmulenson E; Zimmermann N; Mikus G; Joerger M; Jaehde U
    Expert Opin Drug Metab Toxicol; 2021 Dec; 17(12):1407-1422. PubMed ID: 35029518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic drug monitoring of 5-fluorouracil.
    Lee JJ; Beumer JH; Chu E
    Cancer Chemother Pharmacol; 2016 Sep; 78(3):447-64. PubMed ID: 27217046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.